Strides Pharma Science Ltd — Quarterly Results & Earnings

₹937.75

+1.19%

Profit Growth YoY79.67%Latest quarter

Sales Growth YoY4.62%Latest quarter

Sales CAGR 5Y10.65%5 year compound

Profit CAGR 5Y124.04%5 year compound

📋

Quarterly Performance

YoY Profit Growth+79.67%

🔥 Exceptional growth

YoY Sales Growth+4.62%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

10.16%

EPS Growth 5Y

122.76%

Interest Coverage

Higher = safer debt servicing

3.77

ROE

150.67%

ROCE

14.68%

💡

Growth Analysis

Strides Pharma Science Ltd reported YoY profit growth of 79.67% and revenue growth of 4.62% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 10.65% and profits at 124.04% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Strides Pharma Science Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.